 Brief intensive chemotherapy metastatic non-small-cell lung cancer phase II study weekly CODE regimen Fifty-three patients stage IIIB stage IV non-small-cell lung cancer CODE cisplatin vincristine doxorubicin antibiotic prophylaxis antiemetic regimen intensive chemotherapy program weekly treatment planned brief duration weeks patients CODE program antifungal prophylaxis supportive corticosteroids total study population patients treatment complete response median survival entire group weeks weeks stage IIIB weeks stage IV alive year Comparison granulocyte counts patients prednisone subgroup corticosteroids granulocytopenia prednisone Use prednisone improved delivery myelosuppressive drugs CODE patients disease progression constitutional side effects weekly chemotherapy standard chemotherapy patients weeks treatment Serious toxicity uncommon treatment-related deaths episodes neutropenia fever CODE novel treatment non-small-cell lung cancer pilot study outpatient setting week period acceptable incidence toxicity promising level efficacy Additional testing comparison regimens supportive care